Dergiler / İstanbul Kuzey Klinikleri / 2020 / Cilt: 7 - Sayı: 3

Epidemiologic character of COVID-19 in Kazakhstan: A preliminary report

Sayfa
210–213
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Currently, the strict implication of respiratory infection control measurement in public and health care services are still very important.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: Coronavirus Disease 2019 (COVID-19), named the etiological agent of Severe Acute Respiratory SyndromeCoronavirus-2 (SARS-CoV-2) has recently emerged in Wuhan City, Hubei Province, China, in December 2019.
📊
Temel Bulgular & Veri:The data for COVID-19 cases recorded from March 13to April 6, 2020, were obtained from the Sanitary Epidemiological Service.
💡
Sonuç & Katkı:Currently, the strict implication of respiratory infection control measurement in public and health care services are still very important.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE: Coronavirus Disease 2019 (COVID-19), named the etiological agent of Severe Acute Respiratory SyndromeCoronavirus-2 (SARS-CoV-2) has recently emerged in Wuhan City, Hubei Province, China, in December 2019. Kazakhstan’sborder proximity to China has led to preventive measures in the country since January. This study aims to evaluate the epidemiologic characters of the first recorded cases in Kazakhstan.METHODS: Here, we reviewed the preparedness of the infection control and prevention procedures in Kazakhstan and evaluated the epidemiological characters of confirmed cases in Kazakhstan. The data for COVID-19 cases recorded from March 13to April 6, 2020, were obtained from the Sanitary Epidemiological Service. Age, gender and their living place were recorded.The severity of infection, geographical distribution, gender and age group of cases were analyzed.RESULTS: Four phases of preventive measures used in respiratory infections have been implemented in Kazakhstan sinceJanuary 6, 2020. The first case was recorded on March 13. During the period of March 13 and April 06, 629 cases withCOVID-19 were recorded in Kazakhstan. Of these, 45 patients recovered, six had resulted in death; 535 (85%) of caseswere mild and/or asymptomatic, 72 (11.5%) - moderate, 22 (3.5%) - severe. Of these, 7.5% of the cases were registeredas children and course was mild.CONCLUSION: The cases are increasing in Kazakhstan as seen in other countries. Currently, the strict implication of respiratory infection control measurement in public and health care services are still very important.

🔖

Bu Makaleye Atıf Yap

MAUKAYEVA, S., KARIMOVA, S. (2022). Epidemiologic character of COVID-19 in Kazakhstan: A preliminary report. İstanbul Kuzey Klinikleri, Cilt: 7 - Sayı: 3, 210–213. https://ajindex.com/articles/551359

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl) 2020 Feb 11 [E-pub ahead of print], doi:10.1097/CM9.0000000000000722
  2. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. [Article in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2020;41:145–51
  3. World Health Organization. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-atthe-media-briefing-on-2019-ncov-on-11-february-2020. Accessed Apr 14, 2020
  4. Liang T. Handbook of COVID-19 Prevention and Treatment 2020. Available at: https://www.alnap.org/help-library/handbook-of-covid19-prevention-and-treatment. Accessed Apr 14, 2020
  5. Kakimoto K, Kamiya H, Yamagishi T, Matsui T, Suzuki M, Wakita T. Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship - Yokohama, Japan, February 2020. MMWR Morb Mortal Wkly Rep 2020;69:312–3
  6. Centre for Evidence-Based Medicine; Mahtani KR, Heneghan C, Aronson JK. What is the evidence for social distancing during global pandemics? Available at: https://www.cebm.net/covid-19/what-isthe-evidence-for-social-distancing-during-global-pandemics/. Accessed Apr 14, 2020
  7. Lewnard JA, Lo NC. Scientific and ethical basis for social-distancing interventions against COVID-19. Lancet Infect Dis 2020 Mar 23 [Epub ahead of print], doi:10.1016/S1473-3099(20)30190-0
  8. Kilic AU, Kara F, Alp E, Doganay M. New threat: 2019 novel Coronavirus infection and infection control perspective in Turkey. North Clin Istanb 2020;7:95–8
  9. CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:343–6
  10. Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr 2020 Feb 5 [Epub ahead of print], doi:10.1007/s12519-020-00345-5
  11. Shen KL, Yang YH. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue.World J Pediatr 2020 Feb 5 [E-pub ahead of print], doi:10.1007/s12519-020-00344-6
  12. Dong Y, Mo X, Hu Y, Qi X, Jiang